![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Terumo Aortic Gains FDA’s Premarket Approval for its Thoraflex Cardiac Device
Terumo Aortic Gains FDA’s Premarket Approval for its Thoraflex Cardiac Device
UK-based Terumo Aortic has received the FDA’s premarket approval for its Thoraflex Hybrid device for the treatment of patients with complex aortic arch disease.
The single-use device is for so-called “Frozen Elephant Trunk” procedures as a hybrid stent-graft prosthesis to repair or replace damaged or diseased vessels of the aortic arch and descending aorta.
The device, which combines a polyester graft with a self-expanding stent, was designated a Breakthrough Device by the FDA last year.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct